Why Choose Anrate’s Serum-Free Solution?

1. Full Safety Assurance: Block biological hazards at the source

Conventional serum culture has three major drawbacks:

• Contamination risks from animal-derived pathogens (viruses, mycoplasma)
• Immune reactions triggered by heterologous proteins
• Unstable supply caused by shortages of plasma raw materials

The Anrate ART103 series adopts an animal-free, serum-free workflow with a Pichia pastoris expression system, fundamentally resolving safety risks associated with blood-derived products. It meets GMP safety standards for cell therapy and biopharmaceutical manufacturing.

2. Superior Performance for High-Viability, High-Proliferation Culture

• Effectively boosts cell adhesion and proliferation while preserving stem cell pluripotency
• Elevates antibody expression yields and biopharmaceutical output
• Reduces downstream purification steps and production costs (long-term cost cut of over 50%)
• Compatible with numerous cell lines: CHO, HEK293, hybridomas, mesenchymal stem cells, immune cells and more

3. Stable & Self-Sufficient Supply Chain with Domestic Production

• 100% domestically sourced raw materials, free from international supply chain constraints
• Minimal lot-to-lot variation (CV < 5%) for fully reproducible lab results
• Ton-scale production capacity; single batches fulfill large-scale manufacturing needs, cutting validation costs from frequent batch switches